Perspective Therapeutics, Inc. - Director's Dealing 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2017-11-20

Reporting Person: Krachon Michael (VP of Sales & Marketing)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-20	Common Stock	P	19609	$0.50	Acquired	19609	Direct
2017-11-20	Common Stock	P	6965	$0.50	Acquired	26574	Direct
2017-11-20	Common Stock	P	10600	$0.50	Acquired	37174	Direct
2017-11-20	Common Stock	P	700	$0.50	Acquired	37874	Direct
2017-11-20	Common Stock	P	1400	$0.50	Acquired	39274	Direct
2017-11-20	Common Stock	P	126	$0.47	Acquired	39400	Direct
2017-11-20	Common Stock	P	500	$0.47	Acquired	39900	Direct
2017-11-20	Common Stock	P	200	$0.46	Acquired	40100	Direct
2017-11-20	Common Stock	P	10160	$0.50	Acquired	50260	Direct
2017-11-20	Common Stock	P	300	$0.47	Acquired	50560	Direct
2017-11-20	Common Stock	P	40	$0.49	Acquired	50600	Direct
2017-11-20	Common Stock	P	200	$0.48	Acquired	50800	Direct
2017-11-20	Common Stock	P	200	$0.47	Acquired	51000	Direct
2017-11-20	Common Stock	P	100	$0.48	Acquired	51100	Direct
2017-11-20	Common Stock	P	3900	$0.48	Acquired	55000	Direct